New Treatment Strategies for Dengue and Other Flaviviral Diseases / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
$201.40
Used and New from Other Sellers
Used and New from Other Sellers
from $75.60
Usually ships in 1-2 business days
(Save 64%)
Other sellers (Hardcover)
  • All (10) from $75.60   
  • New (6) from $143.43   
  • Used (4) from $75.60   

Overview

Dengue virus is a member of the Flaviviridae family, which includes viruses associated with human diseases such as yellow fever, Japanese encephalitis and hepatitis C. Dengue fever is transmitted by mosquitoes, principally Aedes aegypti. There are four serotypes of dengue virus, of which DENV-2 has been the most prevalent in many recent epidemics. Following primary infection, lifelong immunity develops, preventing repeated assault by the same serotype. However, the non-neutralizing antibodies from a previous infection or maternally acquired antibodies are thought to form complexes with a different serotype during a subsequent infection and cause dengue haemorrhagic fever/dengue shock syndrome, which can be fatal. There is no treatment or vaccine available today that can combat this emerging and uncontrolled disease.

This book features contributions from the world’s leading researchers working on dengue and related flaviviruses who examine the current state of the art in the molecular biology of the dengue virus. Particular emphasis is placed on the structure and function of the virus and the targeting of virus proteins by potential antiviral agents. The pathogenesis of dengue and dengue haemorrhagic fever are discussed in detail, especially the target cells and the specific receptors on these cells, thereby developing a clear overview of host and viral factors that contribute to dengue haemorrhagic fever. Finally, the book reviews the therapeutic options, paying particular attention to ways in which vector, host and environment can play a critical role in the spread of this disease.

With dengue fever and other emerging viral diseases becoming increasingly prevalent around the world, this book provides valuable insight into the virus that causes this disease and potential ways to manage it. It is essential reading for all those working in tropical diseases, public health and virology.

Praise from the reviews:

"The book provides an excellent summary of dengue/flavivirus research and is important for individuals and institutions interested in emerging infectious diseases." MICROBIOLOGY TODAY

Read More Show Less

Editorial Reviews

From the Publisher
"…this reviewer was highly moved by the painstaking investigations and careful evaluation of results by the participants of this symposium." (Journal of Tropical Pediatrics, February 2008)

"This is an excellent update of many aspects of dengue and the difficult quest for treatment and prevention. It is a valuable resource for new researchers coming to this fascinating field." (Doody's Health Services)

"…painstaking investigations and careful evaluation…" (Journal of Tropical Pediatrics, January 2007)

"...provides an excellent summary of dengue/flavivirus research and is important for individual and institutions interested in emerging infectious diseases."  (Microbiology Today, November 2007)

"…this reviewer was highly moved by the painstaking investigations and careful evaluation of results by the participants of this symposium." (Journal of Tropical Pediatrics, February 2008)

Doody's Review Service
Reviewer: Wellington Sun, M.D.(Centers for Disease Control and Prevention)
Description: This publication, the proceedings of the Novartis Foundation Symposium on New Treatment Strategies for Dengue and Other Flaviviral Diseases held in Singapore in September 2005, includes 16 chapters on the topics of dengue epidemiology, structural biology, molecular genetics, biochemistry, animal models, immunology, and vaccinology with chapter-ending discussions by the participating experts. The panel of 34 experts in the field was chaired by Dr. Charles Rice from Rockefeller University.
Purpose: The purpose is actually broader than what the title suggests. This 265-page book is not only a review of the current status of dengue therapeutics and candidate viral targets, it also provides an update on many other fields in the study of dengue. The panel of experts includes many authorities with experience with other viruses and other fields of research. Their insights provide a better understanding of dengue within a broader context and highlight some of the unique features of this virus.
Audience: This book is written mostly for researchers, with heavy emphasis on results of basic research. Virologists, immunologists, molecular biologists, and structural biologists will find plenty of fodder in this book. It also serves well those who are interested in dengue who would like an in-depth update of this rapidly advancing field.
Features: The quality of the chapters is excellent and they are well referenced. The discussions at the end of the chapters are most interesting because they provide the participants' personal views on the subjects. Through these free-wheeling discussions, readers gain insights into what is controversial in the field. However, the sequence of chapters can be organized more logically and the book could benefit from the addition of some discussion of the results of therapeutics that have been tried, such as steroids. The use of passively transferred antibodies as therapy deserves more discussion in this book of treatment strategies.
Assessment: This is an excellent update of many aspects of dengue and the difficult quest for treatment and prevention. It is a valuable resource for new researchers coming to this fascinating field. Hopefully there will be future editions.
Read More Show Less

Product Details

  • ISBN-13: 9780470016435
  • Publisher: Wiley
  • Publication date: 10/23/2006
  • Series: Novartis Foundation Symposia Series , #152
  • Edition number: 1
  • Pages: 276
  • Product dimensions: 6.32 (w) x 9.25 (h) x 0.72 (d)

Meet the Author

The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.

Read More Show Less

Table of Contents

Chair’s introduction (Charles Rice).

Dengue/dengue hemorrhagic fever: history and current status (Duane J. Gubler).

Discussion.

Molecular biology of flaviviruses (Eva Harris, Katherine L. Holden, Dianna Edgil, Charlotta Polacek and Karen Clyde).

Discussion.

Development of novel antivirals against flaviviruses (Chinmay G. Patkar and Richard J. Kuhn).

Discussion.

Entry functions and antigenic structure of flavivirus envelope proteins Karin Stiasny, Stefan Kiermayr and Franz X. Heinz).

Discussion.

General discussion I.

Multiple enzyme activities of flavivirus proteins (R. Padmanabhan, N. Mueller, E. Reichert, C. Yon, T. Teramoto, Y. Kono, R. Takhampunya, S. Ubol, N. Pattabiraman, B. Falgout, V. K. Ganesh and K. Murthy).

Discussion.

Towards the design of flavivirus helicase/NTPase inhibitors: crystallographic and mutagenesis studies of the dengue virus NS3 helicase catalytic domain (Ting Xu, Aruna Sampath, Alex Chao, Daying Wen, Max Nanao, Dahai Luo, Patrick Chene, Subhash G. Vasudevan and Julien Lescar).

Discussion.

Finding new medicines for flaviviral targets (Thomas H. Keller, Yen Liang Chen, John E. Knox, Siew Pheng Lim, Ngai Ling Ma, Sejal J. Patel, Aruna Sampath, Qing Yin Wang, Zheng Yin and Subhash G. Vasudevan).

Discussion.

Structural and functional analysis of dengue virus RNA (Diego Alvarez, Maria F. Lodeiro, Claudia Filomatori, Silvana Fucito, Juan Mondotte and Andrea Gamarnik).

Discussion.

Organization of flaviviral replicase proteins in virus induced membranes: a role for NS1’ in Japanese encephalitis virus RNA synthesis (Vijaya Satchidanandam, Pradeep Devappa Uchil and Priti Kumar).

Discussion.

CRM1 dependent nuclear export of dengue virus type-2 NS5 (Melinda J. Pryor, Stephen M. Rawlinson, Peter J. Wright and David A. Jans).

Discussion.

T cell responses and dengue haemorrhagic fever (Gavin Screaton and Juthathip Mongkolsapaya).

Discussion.

The evolutionary biology of dengue virus (Edward C. Holmes).

Discussion.

Developing vaccines against flavivirus diseases: past success, present hopes and future challenges (John R. Stephenson).

Discussion.

A genomics approach to understanding host response during dengue infection (Martin L. Hibberd, Ling Ling, Thomas Tolfvenstam, Wayne Mitchell, Chris Wong, Vladimir A. Kuznetsov, Joshy George, Swee-Hoe Ong, Yijun Ruan, Chia L Wei, Feng Gu, Joshua Fink, Andy Yip, Wei Liu, Mark Schreiber and Subhash G. Vasudevan).

Discussion.

Mouse and hamsters models rodent models for the study of therapy against flavivirus infections (Nathalie Charlier, Pieter Leyssen, Erik De Clercq and Johan Neyts).

Discussion.

Secretion of flaviviral non-structural protein NS1: from diagnosis to pathogenesis (S. Alcon-LePoder, P. Sivard, M.-T. Drouet, A. Talarmin, C. Rice and M. Flamand).

Discussion.

Final discussion.

Index of contributors.

Subject index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)